Double-Blind, Randomized, Multiple-Dose, Placebo-Controlled, 2-Way Crossover Study To Study Effects Of PF-04457845 On Polysomnographic Endpoints In Healthy Volunteers.

Trial Profile

Double-Blind, Randomized, Multiple-Dose, Placebo-Controlled, 2-Way Crossover Study To Study Effects Of PF-04457845 On Polysomnographic Endpoints In Healthy Volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2010

At a glance

  • Drugs PF 4457845 (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Jan 2010 Actual patient number (18) added as reported by ClinicalTrials.gov.
    • 14 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top